Healthcare provider profile · identity verified

Eric K Baker, MD

Allopathic & Osteopathic Physicians|Internal Medicine · OVERLAND PARK, KS · NPI 1376615690

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Eric K Baker, MD received $118.89 in general payments during 2025 across 1 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 173 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 101 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 124 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$118.89

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$118.89	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$118.89	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
KISUNLA Normalized: kisunla	Drug	Lilly USA, LLC	$118.89	1	2025
Source payment records 2025-11-12 · Lilly USA, LLC · $118.89 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	173	36
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	101	20
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	124	30

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1009	291
Levothyroxine Sodium	Levothyroxine Sodium	557	151
Amlodipine Besylate	Amlodipine Besylate	526	155
Pantoprazole Sodium	Pantoprazole Sodium	498	146
Losartan Potassium	Losartan Potassium	455	136
Rosuvastatin Calcium	Rosuvastatin Calcium	353	105
Gabapentin	Gabapentin	315	90
Tamsulosin Hcl	Tamsulosin Hcl	304	88
Lisinopril	Lisinopril	295	92
Metformin Hcl Er	Metformin Hcl	283	85
Alprazolam	Alprazolam	263	66
Simvastatin	Simvastatin	261	71
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	260	65
Metformin Hcl	Metformin Hcl	249	70
Meloxicam	Meloxicam	233	65
Omeprazole	Omeprazole	223	68
Metoprolol Succinate	Metoprolol Succinate	216	58
Ozempic	Semaglutide	213	39
Tramadol Hcl	Tramadol Hcl	213	69
Alendronate Sodium	Alendronate Sodium	208	58
Hydrochlorothiazide	Hydrochlorothiazide	202	59
Carvedilol	Carvedilol	198	59
Oxycodone Hcl	Oxycodone Hcl	178	28
Trazodone Hcl	Trazodone Hcl	176	54
Jardiance	Empagliflozin	173	36
Potassium Chloride	Potassium Chloride	148	48
Pravastatin Sodium	Pravastatin Sodium	140	32
Escitalopram Oxalate	Escitalopram Oxalate	138	42
Eliquis	Apixaban	137	29
Zolpidem Tartrate	Zolpidem Tartrate	136	38
Allopurinol	Allopurinol	131	41
Trulicity	Dulaglutide	124	30
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	121	31
Ezetimibe	Ezetimibe	113	37
Sertraline Hcl	Sertraline Hcl	113	32
Finasteride	Finasteride	110	36
Duloxetine Hcl	Duloxetine Hcl	108	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	102	17
Albuterol Sulfate Hfa	Albuterol Sulfate	101	40
Mounjaro	Tirzepatide	101	20
Venlafaxine Hcl Er	Venlafaxine Hcl	100	27
Olmesartan Medoxomil	Olmesartan Medoxomil	95	29
Montelukast Sodium	Montelukast Sodium	94	28
Furosemide	Furosemide	90	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	19
Prednisone	Prednisone	87	47
Pioglitazone Hcl	Pioglitazone Hcl	86	20
Fluticasone Propionate	Fluticasone Propionate	85	29
Glipizide Er	Glipizide	85	24
Fluoxetine Hcl	Fluoxetine Hcl	84	23
Pregabalin	Pregabalin	84	19
Celecoxib	Celecoxib	82	24
Diazepam	Diazepam	82	26
Ipratropium Bromide	Ipratropium Bromide	81	29
Citalopram Hbr	Citalopram Hydrobromide	77	23
Baclofen	Baclofen	68	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	17
Spironolactone	Spironolactone	66	23
Clopidogrel	Clopidogrel Bisulfate	64	20
Donepezil Hcl	Donepezil Hcl	64	17
Irbesartan	Irbesartan	64	19
Morphine Sulfate Er	Morphine Sulfate	61	11
Farxiga	Dapagliflozin Propanediol	58	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	16
Metoprolol Tartrate	Metoprolol Tartrate	57	18
Methylprednisolone	Methylprednisolone	56	53
Esomeprazole Magnesium	Esomeprazole Magnesium	54	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	12
Clonazepam	Clonazepam	52	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Synthroid	Levothyroxine Sodium	52	15
Triamcinolone Acetonide	Triamcinolone Acetonide	52	26
Glimepiride	Glimepiride	50	13
Atenolol	Atenolol	49	14
Nystatin	Nystatin	49	16
Lovastatin	Lovastatin	47	13
Acetaminophen-Codeine	Acetaminophen With Codeine	46	suppressed
Benazepril Hcl	Benazepril Hcl	46	12
Solifenacin Succinate	Solifenacin Succinate	45	18
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Lorazepam	Lorazepam	42	12
Paroxetine Hcl	Paroxetine Hcl	42	13
Alfuzosin Hcl Er	Alfuzosin Hcl	41	17
Torsemide	Torsemide	41	14
Estradiol	Estradiol	40	14
Oxybutynin Chloride	Oxybutynin Chloride	40	14
Famotidine	Famotidine	39	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	38	13
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Nebivolol Hcl	Nebivolol Hcl	35	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	35	34
Repatha Sureclick	Evolocumab	35	suppressed
Glipizide	Glipizide	34	suppressed
Topiramate	Topiramate	34	12
Azithromycin	Azithromycin	33	33
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Enalapril Maleate	Enalapril Maleate	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	12
Indapamide	Indapamide	32	12
Mirtazapine	Mirtazapine	32	14
Tizanidine Hcl	Tizanidine Hcl	31	14
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Methimazole	Methimazole	29	suppressed
Valsartan	Valsartan	29	suppressed
Acyclovir	Acyclovir	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	11
Levetiracetam	Levetiracetam	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	16
Amoxicillin	Amoxicillin	26	21
Azelastine Hcl	Azelastine Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	12
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	11
Ibuprofen	Ibuprofen	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	13
Cephalexin	Cephalexin	23	23
Dutasteride	Dutasteride	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	21	suppressed
Colchicine	Colchicine	20	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Cefdinir	Cefdinir	19	16
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Levofloxacin	Levofloxacin	18	13
Nifedipine Er	Nifedipine	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Ramipril	Ramipril	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Estradiol (Once Weekly)	Estradiol	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lactulose	Lactulose	15	suppressed
Linzess	Linaclotide	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Gemtesa	Vibegron	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Thioridazine Hcl	Thioridazine Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Digoxin	Digoxin	11	suppressed
Etodolac	Etodolac	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Testosterone	Testosterone	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$118.89 · 1 records	Lilly USA, LLC	KISUNLA	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error